Innoviva (INVA) Times Interest Earned (2010 - 2026)
Innoviva (INVA) posted Times Interest Earned of $1.43 for Q1 2026, up 133.92% on a QoQ basis from -$4.23 in Q4 2025, and down 8.94% year-over-year from $1.58 in Q1 2025.
Innoviva (INVA) Times Interest Earned (2010 - 2026) Analysis & Trends
Innoviva's Times Interest Earned history runs 17 years deep, the most recent figure standing at $1.43 for Q1 2026.
- Quarterly Times Interest Earned fell 8.94% year-over-year to $1.43 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.44 (down 6.54% YoY) and the FY2025 annual result came in at $3.33, up 274.24% from the prior year.
- Times Interest Earned was $1.43 for Q1 2026 at Innoviva, up from -$4.23 in the prior quarter.
- Across five years, Times Interest Earned topped out at $9.94 in Q3 2023 and bottomed at -$6.58 in Q2 2022.
- A 5-year average of $1.09 and a median of -$0.04 in 2023 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2024 — Times Interest Earned slumped 5323.28% — and 2025, when it soared 341.82%.
- Innoviva's Times Interest Earned stood at -$1.85 in 2022, then jumped by 97.9% to -$0.04 in 2023, then slumped by 5323.28% to -$2.11 in 2024, then slumped by 100.61% to -$4.23 in 2025, then jumped by 133.92% to $1.43 in 2026.
- Business Quant data shows INVA's Times Interest Earned at $1.43 in Q1 2026, -$4.23 in Q4 2025, and $9.32 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 1.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.43 |
| Dec 31, 2025 | -4.23 |
| Sep 30, 2025 | 9.32 |
| Jun 30, 2025 | 1.85 |
| Mar 31, 2025 | 1.58 |
| Dec 31, 2024 | -2.11 |
| Sep 30, 2024 | 7.09 |
| Jun 30, 2024 | 2.12 |
| Mar 31, 2024 | -0.65 |
| Dec 31, 2023 | -0.04 |
| Sep 30, 2023 | 9.94 |
| Jun 30, 2023 | -1.21 |
| Mar 31, 2023 | -1.41 |
| Dec 31, 2022 | -1.85 |
| Sep 30, 2022 | 6.10 |
| Jun 30, 2022 | -6.58 |
| Mar 31, 2022 | -2.74 |
| Dec 31, 2021 | -0.16 |
| Sep 30, 2021 | 19.02 |
| Jun 30, 2021 | 2.22 |